Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mel Walker

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 10, 2008
Health state utility scores in advanced non-small cell lung cancerScott Doyle, Andrew Lloyd, Mel Walker
Pharmacoeconomics|February 1, 2006
Incorporating carer effects into economic evaluationSimon Dixon, Mel Walker, Sam Salek
Journal of Comparative Effectiveness Research|April 4, 2025
The need to consider market access for pharmaceutical investment decisions: a primerSreeram V Ramagopalan, Catherine Bacon, Mel Walker, et al.
Current Medical Research and Opinion|November 26, 2005
The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight lossRachel Rowe, Margaret Cowx, Chris Poole, et al.
Current Medical Research and Opinion|July 13, 2006
The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databasesEamonn Brankin, Mel Walker, Niall Lynch, et al.
Clinical Therapeutics|December 13, 2006
The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and FranceJoyce A Cramer, Niall O Lynch, Anne-Francoise Gaudin, et al.
Current Medical Research and Opinion|October 7, 2006
Assessing the total costs of blood delivery to hospital oncology and haematology patientsSamir Agrawal, Neville Davidson, Mel Walker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical recordsSobana Anandarajah, Tracy Tai, Simon de Lusignan, et al.
Current Medical Research and Opinion|June 15, 2007
An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital settingPeter Barrett-Lee, Danny Bloomfield, Lisa Dougherty, et al.
Breast Cancer Research and Treatment|January 21, 2009
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessmentXiaolei Zhou, David Cella, David Cameron, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|May 10, 2008
Health state utility scores in advanced non-small cell lung cancerScott Doyle, Andrew Lloyd, Mel Walker
Pharmacoeconomics|February 1, 2006
Incorporating carer effects into economic evaluationSimon Dixon, Mel Walker, Sam Salek
Journal of Comparative Effectiveness Research|April 4, 2025
The need to consider market access for pharmaceutical investment decisions: a primerSreeram V Ramagopalan, Catherine Bacon, Mel Walker, et al.
Current Medical Research and Opinion|November 26, 2005
The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight lossRachel Rowe, Margaret Cowx, Chris Poole, et al.
Current Medical Research and Opinion|July 13, 2006
The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databasesEamonn Brankin, Mel Walker, Niall Lynch, et al.
Clinical Therapeutics|December 13, 2006
The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and FranceJoyce A Cramer, Niall O Lynch, Anne-Francoise Gaudin, et al.
Current Medical Research and Opinion|October 7, 2006
Assessing the total costs of blood delivery to hospital oncology and haematology patientsSamir Agrawal, Neville Davidson, Mel Walker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical recordsSobana Anandarajah, Tracy Tai, Simon de Lusignan, et al.
Current Medical Research and Opinion|June 15, 2007
An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital settingPeter Barrett-Lee, Danny Bloomfield, Lisa Dougherty, et al.
Breast Cancer Research and Treatment|January 21, 2009
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessmentXiaolei Zhou, David Cella, David Cameron, et al.
Pageof 2